who's who

3 Houston innovators to know this week

This week's roundup of Houston innovators includes Kristen Phillips of Golden Section Studios, David Aaronson of REVS, and Carolyn Rodz of Hello Alice. Courtesy photos

Editor's note: In this week's roundup of Houston innovators to know, I'm introducing you to three local innovators across industries — from startup and small business support to electric vehicles — recently making headlines in Houston innovation.

Kristen Phillips, director of Golden Sections Studios

Kristen Phillips joined the Houston Innovators Podcast to discuss a new B2B volunteer platform. Photo courtesy of GSS

For years, Golden Section Technology — and its accompanying venture arm — has worked to develop SaaS technology and has created a large network of experts and mentors. Now, the group has created a venture studio to support SaaS startups with this vast network, says Kristen Phillips, director of Golden Section Studios.

Additionally, Phillips says her team has a lot of lessons learned to share with the companies they will support.

"When you're dealing with early-stage companies, a lot of it just boils down to product-market fit and making sure you're able to develop a technology that's scalable that works with your customers as you scale," Phillips says on the Houston Innovators Podcast. "It sounds simple, but it's not easily mastered." Click here to read more.

David Aaronson, CEO and co-founder of REVS

In the coming weeks, REVS plans to set up EV charging stations at properties in Texas and California. Photo courtesy of REVS

Electric Vehicles are growing in popularity, and it's time for the infrastructure to catch up. Houston-based Refuel Electric Vehicle Solutions (REVS), has plans to roll out its offering — consulting, installation, and management services for electric vehicle (EV) charging stations — to multifamily and commercial real estate properties across the U.S. Those properties include apartment complexes, office buildings, hotels, and shopping centers.

As EVs "become more prevalent, it is imperative that commercial real estate and multifamily owners and operators realize that their assets will provide the future infrastructure for charging these vehicles," CEO and Co-founder David Aaronson says.

In the coming weeks, REVS — which Aaronson co-founded with his son, Mike — plans to set up EV charging stations at properties in Texas and California. Click here to read more.

Carolyn Rodz, CEO of Hello Alice

Carolyn Rodz, and her California-based co-founder Elizabeth Gore, recently raised funds to continue to grow Hello Alice, which supports startups and small businesses. Photos via helloalice.com

Machine learning-enabled small business support company Hello Alice, founded in Houston with a presence in California, has closed its $21 million series B raise. The funds come at a pivotal time for the company, which worked hard during the pandemic to support struggling business and now aims to support entrepreneurs of all backgrounds as the world re-emerges out of the COVID-19 era.

"We are thrilled to have a cap table as diverse as the business owners we serve," says Carolyn Rodz, co-founder and CEO of Hello Alice, in the release. "Our investors are leaders from the Black, Hispanic, LGBTQ+, Women, and US Veteran communities. As a Latina founder and fellow small business owner, I want to ensure that as our company grows, we are fueling future diversity in capital and breaking through ceilings for the benefit of our community."

The round, according to a press release, will be used to refine the predictive capabilities on its platform, launch a mobile application, and more. Click here to read more.

Trending News

Building Houston

 
 

From a low-cost vaccine to an app that can help reduce exposure, here are the latest COVID-focused and Houston-based research projects. Photo via Getty Images

While it might seem like the COVID-19 pandemic has settled down for the time being, there's plenty of innovative research ongoing to create solutions for affordable vaccines and tech-enabled protection against the spread of the virus.

Some of that research is happening right here in Houston. Here are two innovative projects in the works at local institutions.

UH researcher designs app to monitor best times to shop

A UH professor is putting safe shopping at your fingertips. Photo via UH.edu

When is the best time to run an errand in the pandemic era we currently reside? There might be an app for that. Albert Cheng, professor of computer science and electrical and computer engineering at the University of Houston, is working on a real-time COVID-19 infection risk assessment and mitigation system. He presented his plans at the Institute of Electrical and Electronics Engineers conference HPC for Urgent Decision Making and will publish the work in IEEE Xplore.

Cheng's work analyzes up-to-date data from multiple open sources to see when is the best time to avoid crowds and accomplish activities outside the home.

"Preliminary work has been performed to determine the usability of a number of COVID-19 data websites and other websites such as grocery stores and restaurants' popular times and traffic," Cheng says in a UH release. "Other data, such as vaccination rates and cultural factors (for example, the percentage of people willing to wear facial coverings or masks in an area), are also used to determine the best grocery store to shop in within a time frame."

To use the app, a user would input their intended destinations and the farthest distance willing to go, as well as the time frame of the trip. The risk assessment and mitigation system, or RT-CIRAM, then "provides as output the target location and the time interval to reach there that would reduce the chance of infections," said Cheng.

There's a lot to it, says Cheng, and the process is highly reliant on technology.

"We are leveraging urgent high-performance cloud computing, coupled with time-critical scheduling and routing techniques, along with our expertise in real-time embedded systems and cyber-physical systems, machine learning, medical devices, real-time knowledge/rule-based decision systems, formal verification, functional reactive systems, virtualization and intrusion detection," says Cheng.

2 Houston hospitals team up with immunotherapy company for new vaccine for Africa

The new vaccine will hopefully help mitigate spread of the disease in Sub-Saharan Africa. Photo via bcm.edu

Baylor College of Medicine and Texas Children's Hospital have teamed up with ImmunityBio Inc. — a clinical-stage immunotherapy company — under a licensing agreement to develop a safe, effective and affordable COVID-19 vaccine.

BCM has licensed out a recombinant protein COVID-19 vaccine candidate that was developed at the Texas Children's Hospital Center for Vaccine Development to ImmunityBio. According to the release, the company engaged in license negotiations with the BCM Ventures team, about the vaccine that could address the current pandemic needs in South Africa.

"We hope that our COVID-19 vaccine for global health might become an important step towards advancing vaccine development capacity in South Africa, and ultimately for all of Sub-Saharan Africa," says Dr. Peter Hotez, professor and dean of the National School of Tropical Medicine at Baylor and co-director of the Texas Children's Hospital Center for Vaccine Development.

ImmunityBio, which was founded in 2014 by Dr. Patrick Soon-Shiong, is working on innovative immunotherapies that address serious unmet needs in infectious diseases, according to a news release from BCM.

"There is a great need for second-generation vaccines, which are accessible, durable and offer broad protection against the emerging variants," says Soon-Shiong. "ImmunityBio has executed on a heterologous ("mix-and-match") strategy to develop a universal COVID-19 vaccine. To accomplish this, we have embarked upon large-scale good manufacturing practices and development of DNA (adenovirus), RNA (self-amplifying mRNA) and subunit protein (yeast) vaccine platforms. This comprehensive approach will leverage our expertise in these platforms for both infectious disease and cancer therapies."

Trending News